These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3312799)

  • 41. Clinical trials and tribulations. Cholesterol veers off script.
    Couzin J
    Science; 2008 Oct; 322(5899):220-3. PubMed ID: 18845747
    [No Abstract]   [Full Text] [Related]  

  • 42. [Comparison of the hypolipemic effects of bezafibrate and fenofibrate in patients with hyperlipoproteinemia type II and IV].
    Sznajderman M
    Przegl Lek; 1984; 41(7):493-9. PubMed ID: 6390536
    [No Abstract]   [Full Text] [Related]  

  • 43. [Familial hypercholesterolemia].
    Widhalm K
    Dtsch Med Wochenschr; 2000 Jan; 125(4):99. PubMed ID: 10733301
    [No Abstract]   [Full Text] [Related]  

  • 44. Prolonged inadvertent pravastatin use in pregnancy.
    Teelucksingh S; El-Youssef J; Sohan K; Ramsewak S
    Reprod Toxicol; 2004; 18(2):299-300. PubMed ID: 15019727
    [No Abstract]   [Full Text] [Related]  

  • 45. [Reduction of cardiovascular events with pravastatin. A pooled analysis of clinical events within the scope of the Pravastatin Atherosclerosis Intervention Program].
    Byington RP; Jukema JW; Salonen JT; Pitt B; Bruschke AV; Hoen H; Furberg CD; Mancini GB
    Fortschr Med; 1996 Mar; 114(8):91-8. PubMed ID: 8647574
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Hyperlipidemia: decreasing lipid values and effects of statins].
    Mathes P
    Z Kardiol; 2002; 91 Suppl 2():25-9. PubMed ID: 12436762
    [No Abstract]   [Full Text] [Related]  

  • 47. A new statin: a new standard.
    Olsson AG
    Am J Manag Care; 2001 May; 7(5 Suppl):S152-4. PubMed ID: 11383378
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Coronary heart disease patient reaches LDL level of 100 mg/dl with atorvastatin: how do you continue treatment next year?].
    Weizel A; Sawicki PT
    MMW Fortschr Med; 2004 Dec; 146(51-52):14, 16. PubMed ID: 15675236
    [No Abstract]   [Full Text] [Related]  

  • 49. [Lipid lowering improved? Therapeutic progress by using biological mechanisms].
    Udelhoven P
    Med Welt; 1982 Sep; 33(36):3. PubMed ID: 7132677
    [No Abstract]   [Full Text] [Related]  

  • 50. [At last, an effective treatment of familial hypercholesterolemia?].
    Hjermann I; Leren T; Berg K; Leren P; Foss OP
    Tidsskr Nor Laegeforen; 1988 Feb; 108(6):493-6. PubMed ID: 3281324
    [No Abstract]   [Full Text] [Related]  

  • 51. When very high cholesterol runs in the family. More than 600,000 Americans have an inherited condition that can cause heart attacks at an early age.
    Harv Heart Lett; 2014 May; 24(9):4. PubMed ID: 25151667
    [No Abstract]   [Full Text] [Related]  

  • 52. Anacetrapib in familial hypercholesterolaemia: pros and cons.
    Raal FJ; Blom DJ
    Lancet; 2015 May; 385(9983):2124-6. PubMed ID: 25743172
    [No Abstract]   [Full Text] [Related]  

  • 53. Alirocumab (Praluent) for Treatment of Hyperlipidemia.
    Turner PL; Barry KA
    Am Fam Physician; 2016 Aug; 94(4):310-1. PubMed ID: 27548598
    [No Abstract]   [Full Text] [Related]  

  • 54. Genzyme's research in cardiovascular disease, putting rare conditions on centre stage.
    Wilkinson E
    Eur Heart J; 2010 Nov; 31(21):2564-5. PubMed ID: 21080525
    [No Abstract]   [Full Text] [Related]  

  • 55. A physically fit woman in her thirties with exertional dyspnoea.
    Bogsrud MP; Græsdal A; Retterstøl K; Holven KB
    Tidsskr Nor Laegeforen; 2017 Mar; 137(6):456-458. PubMed ID: 28332800
    [No Abstract]   [Full Text] [Related]  

  • 56. Gene therapy briefs.
    Philippidis A
    Hum Gene Ther; 2012 Dec; 23(12):1221-3. PubMed ID: 23234557
    [No Abstract]   [Full Text] [Related]  

  • 57. HeFH in real life, how to: More evolocumab than authorized.
    Sbrana F; Dal Pino B; Bigazzi F; Ripoli A; Coceani M; Sampietro T
    Eur J Prev Cardiol; 2020 Dec; 27(19):2079-2080. PubMed ID: 31403877
    [No Abstract]   [Full Text] [Related]  

  • 58. Screening for Lipid Disorders in Children and Adolescents: Recommendation Statement.
    Am Fam Physician; 2016 Dec; 94(12):Online. PubMed ID: 28075093
    [No Abstract]   [Full Text] [Related]  

  • 59. [Inhibition of intestinal absorption as a principle of the treatment of metabolic diseases].
    Frol'kis AV
    Sov Med; 1989; (3):57-60. PubMed ID: 2660306
    [No Abstract]   [Full Text] [Related]  

  • 60. Vascular endothelial growth factor (VEGF) plasma concentrations in coronary artery disease.
    Alber HF; Frick M; Dulak J; Dörler J; Zwick RH; Dichtl W; Pachinger O; Weidinger F
    Heart; 2005 Mar; 91(3):365-6. PubMed ID: 15710722
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.